Trademarks = 1

Forward Citations = 0

Loading Chart...

8 inventors (with patents filed for the assignee):

Cai Gu Huang (5 out of 6 patents)

Ning He (1 out of 18 patents)

Yue Zhao (1 out of 22 patents)

4. Hitesh Bhagavanbhai Mangukiya (1 out of 1 patent)

5. Hailong Zhang (1 out of 16 patents)

6. Abid Hussain (1 out of 1 patent)

7. Ying Xu (1 out of 9 patents)

8. Hui Yuan (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11642333 - Inhalable formulation of a solution containing vilanterol trifenatate and umeclidinium bromide (2023-05-09),

2. 11369760 - Inhalation atomizer comprising a blocking function and a counter (2022-06-28),

3. 11365248 - Formulation of tocilizumab and method for treating COVID-19 by inhalation (2022-06-21),

4. 11304901 - Liposome formulation of fluticasone furoate and method of preparation (2022-04-19),

5. 11304897 - Pharmaceutical formulation containing umeclidinium bromide and vilanterol trifenatate (2022-04-19),

Company Overview

Anovent Pharmaceutical (U.S.), LLC is a research-driven biopharmaceutical company dedicated to developing innovative therapies for respiratory diseases. The company's focus is on advancing treatments for conditions such as asthma, COPD, and pulmonary fibrosis. With a commitment to improving patient outcomes and quality of life, Anovent strives to be a leader in the field of respiratory medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#30 in Newark, NJ

#1,898 in New Jersey

#51,644 in US

Newark, NJ, United States of America

Anovent Pharmaceutical (u.s.), LLC

Forward Citations = 0

8 inventors:

Cai Gu Huang (5 out of 6 patents)

Ning He (1 out of 18 patents)

Yue Zhao (1 out of 22 patents)

4. Hitesh Bhagavanbhai Mangukiya (1 out of 1 patent)

5. Hailong Zhang (1 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Anovent Pharmaceutical (u.s.), LLC. Retrieved from https://idiyas.com/company/anovent-pharmaceutical-u-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]